FDA Expands Auvelity Approval To Treat Agitation In Alzheimer's Patients
2h
Breaking
1
The FDA on Tuesday, May 12, 2026, expanded approval of Auvelity to treat agitation tied to Alzheimer's dementia in adults, making it the first non-antipsychotic option cleared for that symptom. Fox News
